Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
5.31
+0.39 (7.93%)
At close: Sep 12, 2025, 4:00 PM EDT
5.34
+0.03 (0.56%)
After-hours: Sep 12, 2025, 7:55 PM EDT
Artelo Biosciences Employees
Artelo Biosciences had 6 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,750,500
Market Cap
10.42M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6 | 0 | - |
Dec 31, 2023 | 6 | -1 | -14.29% |
Dec 31, 2022 | 7 | 2 | 40.00% |
Dec 31, 2021 | 5 | 0 | - |
Aug 31, 2021 | 5 | 2 | 66.67% |
Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ARTL News
- 7 days ago - Artelo Biosciences Announces Closing of $3.0 Million Public Offering - GlobeNewsWire
- 9 days ago - Artelo Biosciences Announces Pricing of $3.0 Million Public Offering - GlobeNewsWire
- 9 days ago - Artelo Biosciences Announces Proposed Underwritten Public Offering - GlobeNewsWire
- 10 days ago - Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results - GlobeNewsWire
- 10 days ago - Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS) - GlobeNewsWire
- 19 days ago - Artelo Biosciences Announces New Data from an Initial Food Effect Investigation with ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain - GlobeNewsWire
- 4 weeks ago - Artelo Biosciences Provides Business Update and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13 - GlobeNewsWire